Blog
RSS FeedPosted by Michael Wonder on 15 Dec 2024
ARS Pharmaceuticals announces filings for approval of neffy in China, Japan and Australia
12 December 2024 - Licensing partners in key Asia Pacific countries have filed for approval of neffy (epinephrine nasal spray) ...
Posted by Michael Wonder on 13 Nov 2024
How the Morrison Government passed over an Australian company for a US pharmaceutical giant
13 November 2024 - Australia’s audit office will probe the Morrison Government’s $2 billion deal with US pharmaceutical giant Moderna ...
Posted by Michael Wonder on 18 Oct 2024
Update on regulatory review of lecanemab for early Alzheimer's disease in Australia
17 October 2024 - Eisai announced today that the TGA of Australia issued a public statement about the initial decision ...
Posted by Michael Wonder on 17 Oct 2024
TGA's decision to not register lecanemab (Leqembi)
16 October 2024 - The TGA has made the decision not to register lecanemab (Leqembi) for the treatment of patients ...
Posted by Michael Wonder on 17 Oct 2024
Experts label TGA’s decision to not register Alzheimer’s drug ‘extremely disappointing’
16 October 2024 - A drug that could hold the key to delaying symptoms of devastating Alzheimer’s disease will not be ...
Posted by Michael Wonder on 03 Oct 2024
KalVista announces the submission of additional marketing authorisation applications for sebetralstat for the oral on-demand treatment of hereditary angioedema
30 September 2024 - If approved, sebetralstat will be the first, oral on-demand treatment for HAE. ...
Posted by Michael Wonder on 12 Sep 2024
Diabetes drug Mounjaro approved for obesity treatment by TGA
11 September 2024 - An in-demand diabetes drug that went viral for its weight-loss side effect has been approved to ...
Posted by Michael Wonder on 28 Aug 2024
Mark Butler secures 22 million IV fluid bags amid major shortage
27 August 2024 - The federal government has secured 22 million bags of IV fluids amid a major supply shortage ...
Posted by Michael Wonder on 21 Aug 2024
Dying patients up for $4,000 painkillers in drug supply crisis
21 August 2024 - Dying patients may have to pay more than $4,000 for a box of imported pain-killing tablets ...
Posted by Michael Wonder on 17 Aug 2024
Intravenous scandal escalates: the excuses are fluid
15 August 2024 - A shortage of intravenous IV fluid bags that is causing chaos in Australian hospitals is being ...
Posted by Michael Wonder on 03 Aug 2024
Wegovy, a weight loss drug similar to Ozempic, will be sold in Australia from August 5
3 August 2024 - A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within ...
Posted by Michael Wonder on 22 May 2024
Protecting Australians from unsafe compounding of replica weight loss products
22 May 2024 - The Albanese Government is acting to protect Australians from the risks posed by injecting potentially unsafe ...
Posted by Michael Wonder on 16 Apr 2024
Norgine submits marketing authorisation application via Project Orbis for eflornithine (difluoromethylornithine) in high-risk neuroblastoma
15 April 2024 - Norgine today announced its first marketing authorisation application submissions on 10 April 2024, seeking approval for eflornithine ...
Posted by Michael Wonder on 04 Mar 2024
COVID-19 2024 vaccine advice
29 February 2024 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation ...
Posted by Michael Wonder on 29 Feb 2024
Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug
29 February 2024 - The TGA will move to ban compounding pharmacists from making their own versions of injectable weight ...